Program Leaders: Warren Pear, MD, PhD and E. John Wherry, PhD
The Immunobiology Program aims to:
- Understand the fundamental aspects of immune biology, including activation, differentiation, inactivation, and transformation as these relate to cancer
- Forge a comprehensive understanding of tumor immune surveillance using state-of-the-art in vitro, animal model, and human experimental systems
- Translate novel clinical strategies for immunotherapy of cancer by the design, implementation, and analysis of proof-of-concept human clinical trials
The members’ collective expertise serves as a rich resource for the pursuit of interdisciplinary approaches to fundamental questions about the immunobiology and immunotherapy of cancer. Members include national leaders in basic immunology, tumor immunobiology and translational immunotherapy.
Immunobiology Program Membership
- David Allman, PhD
- Yair Argon, PhD
- Gregory Beatty, MD, PhD
- Janis Burkhardt, PhD
- Michael Cancro, PhD
- Beatriz Carreno, PhD
- Youhai Chen, MD, PhD
- Yongwon Choi, PhD
- Ronald DeMatteo, MD, FACS
- Scott Diamond, PhD
- Bruce Freedman, VMD, PhD, MS
- Malay Haldar, MD, PhD
- Wayne Hancock, MD, PhD, FRCPA
- Jorge Henao-Mejia, MD, PhD
- Christopher Hunter, PhD
- Martha Jordan, PhD
- Carl June, MD
- Mark Kahn, MD
- Taku Kambayashi, MD, PhD
- David Kaplan, MD, MSc
- John Lambris, PhD
- Terri Laufer, MD
- Anh Le, DDS, PhD
- Eline Luning Prak, MD, PhD
- Nicola Mason, PhD, VMD
- Michael May, PhD, MSc
- Michael Milone, MD, PhD
- Jonni Moore, PhD
- Una O’Doherty, MD, PhD
- Paula Oliver, PhD
- Yvonne Paterson, PhD
- Warren Pear, MD, PhD
- Daniel Powell, PhD
- James Riley, PhD
- Kathleen Sullivan, MD, PhD
- Christina Twyman-Saint Victor, MD, MTR
- Robert Vonderheide, MD, DPhil
- Drew Weissman, MD, PhD
- E. John Wherry, PhD